Showing results (241-250 of 716) with videos related to
Sort By:
Pageof 72
Cancer|August 31, 2010
Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapyFarshid Dayyani, Hagop Kantarjian, Susan O'Brien, et al.Cancer|May 26, 2010
Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapyDushyant Verma, Hagop Kantarjian, Jianqin Shan, et al.American Journal of Clinical Pathology|October 6, 2005
inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five casesMihai Merzianu, L Jeffrey Medeiros, Jorge Cortes, et al.The Oncologist|September 5, 2006
Advances in the therapy of chronic idiopathic myelofibrosisCecilia Arana-Yi, Alfonso Quintás-Cardama, Francis Giles, et al.Blood|April 17, 2009
Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Dan Jones, et al.Clinical Lymphoma, Myeloma & Leukemia|May 15, 2012
Phase I-II study of bendamustine in patients with acute leukemia and high risk myelodysplastic syndromeChristelle Chacar, Elias Jabbour, Farhad Ravandi, et al.Current Medical Research and Opinion|November 13, 2009
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patientsEric Q Wu, Scott Johnson, Nicolas Beaulieu, et al.Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Patterns of molecular response to and relapse after combination of sorafenib, idarubicin, and cytarabine in patients with FLT3 mutant acute myeloid leukemiaAref Al-Kali, Jorge Cortes, Stefan Faderl, et al.Cancer|April 21, 2012
Reverse phase protein array profiling reveals distinct proteomic signatures associated with chronic myeloid leukemia progression and with chronic phase in the CD34-positive compartmentAlfonso Quintás-Cardama, Yi Hua Qiu, Sean M Post, et al.Clinical Lymphoma, Myeloma & Leukemia|November 7, 2017
Outcomes of Patients With Relapsed Core Binding Factor-Positive Acute Myeloid LeukemiaMaliha Khan, Jorge Cortes, Wei Qiao, et al.Pageof 72